key: cord-0710914-xfaqf5pu authors: Jothimani, Dinesh; Kailasam, Ezhilarasan; Danielraj, Silas; Nallathambi, Balaji; Ramachandran, Hemalatha; Sekar, Padmini; Manoharan, Shruthi; Ramani, Vidyalakshmi; Narasimhan, Gomathy; Kaliamoorthy, Ilankumaran; Rela, Mohamed title: COVID-19: Poor outcomes in patients with Zinc deficiency date: 2020-09-10 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2020.09.014 sha: c9a9d15a5cb633ef6a3b640e8363503422884865 doc_id: 710914 cord_uid: xfaqf5pu Background Zinc is a trace element with potent immunoregulatory, antiviral properties and is utilized in the treatment of COVID-19. However, we do not know the clinical significance of serum Zinc level in COVID-19 patients. Aim To determine the clinical significance of serum Zinc in COVID-19 patients and to establish a correlation with disease severity. Methodology A prospective study on COVID-19 patients underwent fasting Zinc level at the time of hospitalisation. An initial comparative analysis was carried out between COVID-19 patients and healthy controls. Zinc deficiency COVID-19 patients were compared to those with normal levels. Results COVID-19 patients (n = 47) showed significantly low Zinc levels compared to healthy controls (n = 45), median 74.5 (IQR 53.4-94.6) vs 105.8 (IQR 95.65120.90) µg/dl, P < 0.001. Amongst COVID-19 positive patients, 27 (57.4%) were found Zinc deficient. These patients were found to have higher complications (P = 0.009), ARDS (18.5% vs 0%, P = 0.06), received corticosteroid therapy (P = 0.02), prolonged hospital stay (P = 0.05) and increased mortality (18.5% vs 0%, P = 0.06). The Odds ratio (OR) of developing complications in Zinc deficient COVID-19 patients was 5.54. Conclusion Our data clearly shows that significant number of COVID-19 patients are Zinc deficient. These Zinc deficient patients developed more complications with prolonged hospital stay and were associated with increased mortality. Background: COVID-19 pandemic caused by SARS-CoV-2 is a major healthcare problem around the world with significantly higher morbidity and mortality in patients with coexisting conditions such as diabetes mellitus and hypertension 1, 2 . Clinical presentation can be heterogenous from being asymptomatic to severe disease which can be associated with cytokine storm. Pathogenesis of COVID-19 is not fully understood but is probably multifactorial causing systemic hyperinflammatory response and associated thromboembolic complications in severe cases 3, 4 . Zinc is a trace element with potent immunoregulatory and antiviral properties. Zinc is essential for growth, reproductive health, immunity and neurobehavioral development 5 . Recommended daily intake of zinc ranges between 3 -16 mg. Under physiological conditions, Zinc is essential for cellular growth and maturation of immune cells, particularly in the development and activation of T-lymphocytes 6 . Studies show around 10% of our body proteins utilizes Zinc and is a cofactor in at least two-hundred immunomodulatory and antioxidant reactions 7 . Prolonged deficiency is associated with immune system dysfunction, sterility in males, neurosensory disorders and decreased body mass 8 J o u r n a l P r e -p r o o f Until now, there is no definitive curative therapy for COVID-19. Therefore, the current treatment involves a multimodal approach with corticosteroids, antivirals and anticoagulation therapy. Multivitamin supplements are not uncommon in 'flu' prescriptions. Supplementation with Zinc is increasingly recommended in the management of COVID-19 patients 12, 13 . However, it is unclear whether these patients are actually deficient in Zinc. To determine the clinical significance of serum Zinc level in COVID-19 patients and to establish a correlation with disease severity. Methodology: A prospective observational study was conducted from 17 th May 2020 to 27 th May 2020 to test serum Zinc levels in all consecutive SARS-CoV-2 RT-PCR positive patients referred to our Dr Rela Institute and Medical centre, Chennai, for secondary and tertiary care management of COVID-19 patients. This is a multi-speciality tertiary care institution, currently managing a significant volume of patients with COVID-19. About 5ml blood was collected after an informed consent in a BD gel vacutainer after 6 hours fasting from the time of hospital admission. Biochemical analysis was performed on the serum sample after separation and Zinc level was measured with fully automated Indiko Plus (Thermo Scientific, USA) analyzer using colorimetric method. The reference range used for Zinc concentration was 80-120 µg/dl. To verify the accuracy of the method, two levels of random control A descriptive statistical analysis was carried out for all variables using SPSS v21.0 consisting of mean, standard deviation, percentage, median and interquartile range (IQR: 25%, 75%). Proportions/Associations between characteristics of the study groups were compared by Fisher's exact test. Mann-Whitney U-test and t-test was used to compare continuous variables between the study groups. An univariate logistic regression analysis was carried out to identify Odds Ratio and for evaluation of 95% Confidence Intervals. Results were considered statistically significant when the P value was <0.05. with Zinc deficiency and Normal zinc levels, respectively (Table 1 ). In total, 14 (29.7%) patients received corticosteroids, commenced at day 5 (median, 1-7 days) from the time of admission of whom 12 (85.7%) were in the Zinc deficient patients. Twelve patients received oxygen therapy during the hospital stay, including 6 patients on invasive mechanical ventilation. Zinc -viral particle interplay has been studied previously with other RNA viruses like Hepatitis C, Coronavirus, HIV and Influenza 18, 19, 20, 21 . Zinc supplements are traditionally prescribed for common cold ailments, usually caused by coronaviruses. Zinc supplements were associated with shortened duration of symptoms, reduced severity of illness and more importantly it was associated with reduced morbidity and mortality in children 22 . Zinc has shown to exhibit antiviral property by inhibition of RNA synthesis, viral replication, DNA polymerase, reverse transcriptase and viral proteases 9, 23, 24 . However, literature is unclear with SARS-CoV-2 and Zinc. Interestingly, Hydroxychloroquine, a drug used initially in the management of COVID-19, is an ionophore that transports Zinc across the hydrophobic cell membrane 24, 25 . Moreover, evidences specifically suggest that Zinc supplemented with antiviral drugs containing Zinc-ionophores precisely targets and binds to SARS-CoV-2 preventing its replication within the infected host cells 26 . Intracellularly, Zinc binds with RNA dependent RNA polymerase causing elongation inhibition and decreased template binding of the viral mRNA 25, 26 . Zinc plays a major role at various levels in the process of immune development and acts as an immunomodulator. Zinc deficiency has been associated with poor development of lymphoid tissue, reduced Natural Killer (NK) cell function leading to poor innate immunity 27 . Zinc deficiency is associated with reduced macrophage activation and cytokine generation. Zinc is involved in T-cell and B-cell function. Thymulin, a zinc dependent thymus hormone binds to T-cell receptor and promotes T-cell maturation and cytotoxicity. 8 In addition, Zinc deficiency is associated with downregulation of Interferon gamma, resulting in severe impairment of cell mediated immunity. Also, it enhances the production of interleukins particularly IL-2 via activation of Nuclear Factor kB (NFkB) 28 Ours is a single centre study with limited number of patients, requiring hospitalisation for COVID-19. It would be interesting to study Zinc level and its role in the entire spectrum of the disease including asymptomatic patients with no comorbid conditions who are Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review The immune system and COVID-19: Friend or foe? The CoV-2 outbreak: how hematologists could help to fight Covid-19 International Zinc Nutrition Consultative Group (IZiNCG) technical document #1 Assessment of the risk of zinc deficiency in populations and options for its control Immune-enhancing role of vitamin C and zinc and effect on clinical conditions Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis Zinc in human health: effect of zinc on immune cells The Role of Zinc in Antiviral Immunity Zinc deficiency and advanced liver fibrosis among HIV and hepatitis C co-infected anti-retroviral naïve persons with alcohol use in Russia Zinc and respiratory tract infections: Perspectives for COVID-19 (Review) Early Nutritional Interventions with Zinc, Selenium and Vitamin D for Raising Anti-Viral Resistance Against Progressive COVID-19 Potential role of zinc supplementation in prophylaxis and treatment of COVID-19 An experimental study of the effect of zinc on the activity of angiotensin converting enzyme in serum ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli Inhibition of HIV-1 infection by zinc group metal compounds Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine The Potential Impact of Zinc Supplementation on COVID-19 Factors Attenuating Zinc Deficiency Improvement in Direct-Acting Antiviral Agent-Treated Chronic Hepatitis C Virus Infection Chloroquine is a zinc ionophore Can Zn Be a Critical Element in COVID-19 Treatment? Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture Zinc and immune function: the biological basis of altered resistance to infection Zinc activates NF-kappaB in HUT-78 cells Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis Epub ahead of print Artery Disease; HT-Systemic Hypertension; DM-Type 2 Diabetes Mellitus ARDS-Acute Respiratory Distress Syndrome; MODS-Multi-organ Dysfunction syndrome WCC-White Cell Count; CRP-C-reactive Protein; Supplements-Vitamin C 500MG twice a day and Zinc 150mg once a day